Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

APLD Applied Digital Corporation Common Stock
$30.02 -2.30% -0.71
Notify me if price changes either direction
Interactive Brokers Logotype

Buy APLD stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 8.6B
Enterprise value 10.9B
Forward PE -57.055553
PEG Ratio -57.055553
Enterprise to EBITDA 783.015
Enterprise to revenue 34.103
Price to book MRQ 5.560368
Price to sales TTM 27.577847

Financials

Fiscal Year Ends 2025-05-31
Most Recent Quarter (MRQ) 2026-02-28
Revenue (TTM) 319.3M
EBITDA 13.9M
Diluted EPS TTM -0.38
Total Cash (MRQ) 1.7B
Current ratio (MRQ) 2.382
Operating Cash Flow (TTM) -36005000

APLD trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.